miR-18a induces myotubes atrophy by down-regulating IgfI

Area of Science:

• Molecular Biology
• Muscle Physiology

Background:

• Muscle atrophy results from an imbalance between protein synthesis and degradation.
• Insulin-like Growth Factor 1 (Igf1) is crucial for muscle protein synthesis and hypertrophy, counteracting atrophy via the PI3K/Akt pathway.
• Age-related muscle atrophy is a significant clinical concern.

Purpose of the Study:

• To investigate the role of microRNA-18a (miR-18a) in skeletal muscle physiology and its potential involvement in muscle atrophy.
• To elucidate the molecular mechanisms by which miR-18a influences muscle mass and function.

Main Methods:

• Analysis of miR-18a expression during C2C12 myoblast differentiation and mouse muscle development.
• Functional studies involving forced expression of miR-18a in myotubes.
• Investigation of downstream targets and signaling pathways, including Igf1, Akt, and FoxO3.
• Utilizing PI3K/Akt pathway inhibitors.

Main Results:

• miR-18a expression was found to be down-regulated during myoblast differentiation and muscle development.
• Forced expression of miR-18a led to myotube atrophy and increased expression of atrophy markers (MuRF1, Atrogin-1, CTSL).
• miR-18a suppressed Igf1 expression in a 3'UTR-dependent manner and decreased Akt/FoxO3 phosphorylation, indicating PI3K/Akt pathway inhibition.

Conclusions:

• miR-18a plays a significant role in regulating muscle mass and function.
• miR-18a induces muscle atrophy, partly by suppressing Igf1 and inhibiting the PI3K/Akt pathway.
• miR-18a represents a potential therapeutic target for skeletal muscle atrophy.